Comparison of (68)Ga-labeled Prostate-specific Membrane Antigen Ligand Positron Emission Tomography/Magnetic Resonance Imaging and Positron Emission Tomography/Computed Tomography for Primary Staging of Prostate Cancer: A Systematic Review and Meta-analysis

CONTEXT: In December 2020, the US Food and Drug Administration approved a (68)Ga-labeled prostate-specific membrane antigen ligand ((68)Ga-PSMA-11) for positron emission tomography (PET) in patients with suspected prostate cancer (PCa) metastasis who are candidates for initial definitive therapy. (6...

Descripción completa

Detalles Bibliográficos
Autores principales: Ling, Sui Wai, de Jong, Anouk C., Schoots, Ivo G., Nasserinejad, Kazem, Busstra, Martijn B., van der Veldt, Astrid A.M., Brabander, Tessa
Formato: Online Artículo Texto
Lenguaje:English
Publicado: Elsevier 2021
Materias:
Review – Prostate Cancer
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488242/
https://www.ncbi.nlm.nih.gov/pubmed/34632423
http://dx.doi.org/10.1016/j.euros.2021.09.006

Internet

https://www.ncbi.nlm.nih.gov/pmc/articles/PMC8488242/
https://www.ncbi.nlm.nih.gov/pubmed/34632423
http://dx.doi.org/10.1016/j.euros.2021.09.006

Ejemplares similares